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Therapies for corneal disease and injury often rely on artificial implants, but integrating cells 
into synthetic corneal materials remains a significant challenge. Formed using electrochemical 
techniques to manipulate protein aggregation, a collagen-based material shows promise as a 
scaffold for corneal repair. There is histological and molecular evidence for a specific 
interaction of corneal fibroblasts with this novel transparent matrix scaffold material.  Most 
significantly, the electrochemically produced matrix is non-toxic to cells and controls the 
proliferation in the corneal fibroblasts seeded onto it. This is similar to the behavior of corneal 
stromal cells in a native corneal environment.  Not only is this result is an important first step 
toward developing a more realistic, multi-component artificial cornea, but it also opens 
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Introduction  
The corneal stroma, containing keratocytes and a range of extracellular matrix 
molecules, contributes to a highly specialized microenvironment that maintains healthy 
vision. Disease and injury to the cornea can lead to unhindered cell proliferation, tissue 
dysregulation, or loss of its optical transparency.  A corneal transplant (keratoplasty) is a 
possible remedy when severe degradation occurs, but there are significant risks such as graft 
rejection.[1] As an alternative, corneal repair could also be facilitated by replacing damaged or 
diseased tissue with a scaffold that promotes appropriate regeneration by either native 
(autologous) or donor (homologous) corneal fibroblast cells.[2]  To be medically viable, 
artificial cornea materials should support corneal cell activity without instigating the kind of 
uncontrolled growth that occurs in tumors.  In short, the material must provide the correct 
chemical, structural and mechanical environment to the cells in order to regulate their 
response. 
Biocompatible matrix scaffolds are widely studied,[3-5] and there are numerous 
commercial matrices that support and/or stimulate cell growth (including Matrigel and 
fibronectin glue). Many of these matrices are naturally derived composite materials that 
involve different kinds of proteins and growth factors that promote cell attachment and 
growth.[4] In vitro studies have shown that cell attachment can be guided through 
topographical, chemical, or mechanical cues.[5]  However, the mechanisms behind cell 
attachment and growth at different kinds of surfaces remains a complex and discipline-wide 
question. Artificial scaffolds used in corneal implants can also suffer from issues such as lack 
of transparency and discoloration, as well as mechanical failures.[2] 
For cell growth studies, immortalized cell lines are often convenient. Unlike normal 
cells that eventually cease division once chromosomal DNA becomes damaged, immortalized 
cell lines (including cancer and stem cells) are designed to divide indefinitely. In the context 
of in vitro cell culture studies, immortalized - but contact-inhibited - cells slow their 
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proliferation rates when they run out of space. Conversely, immortalized and transformed 
cells continue to proliferate on top of each other when they run out of surface space.  In vivo, 
unchecked cell growth is the hallmark of transformed cancerous cells. Thus, it is 
advantageous to identify cell culture matrices that encourage contact inhibition and do not 
support cell transformation. 
Different cell lines do not necessarily respond the same way to a given matrix, so it is 
important to test cell viability using application-appropriate lines. Gendron et al. derived an 
immortalized cell line, MK/T-1, from mouse corneal stromal cultures.[6]   These cells are not 
senescent and do not exhibit a transformed phenotype; in other words, these cells continue to 
divide but do not lose control of their proliferation. In this regard, MK/T-1 cells are very 
unique because they are the only reported existing immortalized cell line that recapitulates the 
corneal fibroblast phenotype without a cancerous (oncogenic) transformation. These cells 
retain properties of specific phenotypic stages of corneal fibroblasts: they upregulate 
expression of smooth muscle alpha-actin (ASMA), a marker of myofibroblastic 
transdifferentiation, and activate the p38 mitogen-activated protein Kinase (p38 MAPK) 
pathway upon transforming growth factor beta (TGF-beta) induction.[7]  Furthermore, MK/T-
1 cells have served several research groups as a useful model for corneal stromal cell 
biology.[8]  
This in vitro study demonstrates a successful first step toward potential therapeutic, 
cornea-specific applications of a scaffold material that limits the growth of an immortalized 
cell line without killing the cells.  
 
Experimental Section  
Matrix scaffolds 
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An electrochemically induced collagen aggregation procedure, based on isoelectric focusing 
between parallel plate electrodes, was applied to an electrolyte containing type I collagen 
monomers (0.07 mg/mL from 3 mg/mL Vitrogen stock solution, Inamed Biomaterials) in 
ultrapure water (18.2 MΩ•cm, Barnstead Nanopure) adjusted to pH 7 with NaOH (EMD 
chemicals, ACS reagent grade) [9]. A potential (8 V for 30 minutes) applied to this electrolyte 
caused the formation of a transparent membrane (thickness ~ 500 µm, with surface area ~ 1 
cm x 2.5 cm). Membranes were placed immediately on sterile culture dishes and refrigerated 
until cell culture studies commenced. Parallel sets of membranes were prepared for materials 
characterization.  They were dried onto glass slides for atomic force microscopy and force 
spectroscopy  (Asylum Research MFP-3D), Raman spectroscopy (Jobin Yvon Horiba 
LabRAM, confocal, 532 nm excitation), and Scanning Electron Microscopy (SEM) 
investigations (FEI Quanta 400 environmental SEM, with carbon-coated specimens). Wet 
membranes were used for ultraviolet (UV)-visible absorption spectroscopy (OceanOptics 
USB2000).  
Control thermally fibrilized collagen specimens were prepared by fibrilizing collagen 
by incubating the same monomeric starting collagen (0.1 mg/mL from 3 mg/mL Vitrogen 
stock solution, Inamed Biomaterials) in a phosphate buffer at pH 6 at 37 ºC for 4 hours.  
Additional control experiments were performed in standard polystyrene tissue culture plates 
with no collagen present. 
Cell Cultures 
Standard polystyrene tissue culture plates holding the collagen matrix were UV-sterilized (10 
minutes, 30 W/3 A bulb) in a tissue culture laminar flow cabinet, then washed with 
Dulbecco’s Modified Eagle Medium (DMEM, 3 times for 5 minutes). MK/T-1 cells were 
trypsinized, washed, counted and then replated onto the scaffold coated plates (0.17 x 106 
cells per 21 cm2) or simultaneously and at the same density onto the same type of standard 
untreated tissue culture plates in DMEM with fetal bovine serum (FBS, 10%). Cells were 
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allowed to gently settle onto the matrix and/or the untreated tissue culture plates before 
standard tissue culture incubation (37 ºC, humidified 5% CO2 atmosphere) to maintain 
exponential growth conditions. Some experiments required cultures incubated with 5-bromo-
2-deoxyuridine (BrdU, 1 hour at 37 ºC).  Cultures were maintained for 48 hours before 
harvesting. 
Histology 
Cell/scaffold co-cultures and plastic replated cultures were gently scraped from the dishes 
after 48 hours of culture and centrifuged (1000 rpm for 5 minutes) to gently pellet the cells 
and matrix. Pellets were fixed in phosphate buffered saline with paraformaldehyde (4%) for 
48 hours before embedding in a low-melting-temperature agarose and subsequent embedding 
in paraffin blocks so that 5 µm serial sections could be generated, numbered and registered. 
Hematoxylin and eosin (H&E) staining on every 20th section mapped the location and 
integrity of cell-matrix materials. Sections identified by H&E mapping were used for 
immunohistochemistry analysis of gene expression. To ensure that differences in expression 
of PCNA and BrdU staining are meaningful (and not due to differences in cell integrity), 
sections adjacent to those used for PCNA/BrdU studies were treated with histological H&E 
stain. H&E staining indicates a sufficient number of cells for both types of cultures, and 
evidence of robust α-tubulin protein expression in matrix-cultured cells provides a further 
positive control for cellular integrity and protein expression integrity in matrix cultures. 
Tubulin is a cytoskeletal scaffolding protein that plays a critical role in processes such as cell 
division.  
Antibodies 
Antibodies used in this study include rabbit anti-phospho-p44/42 MAPK (Thr202/Tyr204, 
New England Biolabs, Beverly MA, used at 1/2000 for western blotting and 1/250 for 
immunohistochemistry), rabbit anti-p44/42 MAPK (Santa Cruz Biotechnology, used at 
dilutions of 1/1000 for western and 1/250 for immunohistochemistry), rabbit anti-PCNA (FL-
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261, Santa Cruz Biotechnology, Inc. USA,  used at 1/2000 for western blotting and 1/100 for 
immunohistochemistry), mouse monoclonal DM1 anti-Tubulin (Sigma, St. Louis MI,  used at 
1 µg/ml for western and 1/250 dilution for immunohistochemistry), mouse monoclonal 1A4 
anti-ASMA (Sigma, St. Louis MI,  used at 1/6500 for western and 1/200 for 
immunohistochemistry) and mouse monoclonal anti-BrdU (Sigma, St. Louis MI, used at 
1:100 for immunohistochemistry). Appropriate chromogen conjugated secondary antibody 
reagents (Promega, Madison WI) were used to develop the reactions.  
Immunohistochemistry 
Immunohistochemical staining was performed sections that were deparaffinized in xylene and 
graded ethanols and then held in Tris buffered saline (TBS). Sections were blocked in ECL 
Advance Blocking Agent (GE Healthcare, Buckinghamshire UK, ~2 hrs in 2%,  in TBS with 
0.1% Triton X-100 added for nuclear markers phospho-MAPK, PCNA and BrdU). After 
blotting the blocking solution, sections were treated with primary antibodies in ECL Advance 
Blocking Agent in TBS overnight. Sections were washed in TBS (3 times for 10 minutes) and 
then incubated in either anti-rabbit Ig Alkaline Phosphatase, anti-mouse Ig Alkaline 
Phosphatase or, in the case of tubulin, peroxidase (Promega, in 2% ECL Advance Blocking 
Agent in TBS at 1/200 dilution for ~2 hours). After washing in TBS (3 times for 10 minutes), 
sections were developed using Vector Red AP with Levamisole (Vector Laboratories, 
Burlingame CA USA) or Vector NovaRed (Vector Laboratories, Burlingame CA USA) for 
peroxidase conjugated secondary antibodies. Sections were then air dried and mounted with 
Permount. 
Western blot analysis 
Western blots were performed by standard procedures as previously described.[6] Cells were 
isolated from surrounding matrix scaffold by incubating the material in Versene EDTA 
solution (37 ºC) with gentle pipetting, while cells which had been replated on standard tissue 
culture plastic could be gently scraped from the dishes.  Chemiluminescence detection 
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reagents (Amersham Biosciences, Piscataway, NJ) allowed measurement of ASMA, phospho-
p44/42 MAPK, p44/42 MAPK, PCNA using the antibody reagents described above for 
immunohistochemistry. ASMA Western blots were stripped and re-probed with anti-α-tubulin 
monoclonal antibody to verify protein integrity and loading equivalency. Phospho-p44/42 
MAPK Western blots were stripped and reprobed with anti-p44/42 MAPK and PCNA. 
Densitometry analyses were conducted using the Kodak Gel Logic Imaging System (Eastman 
Kodak Company, Rochester, NY) and intensities of the expressed bands were analyzed using 
Kodak Molecular Imaging Software (Version 4.0). ASMA and PCNA band intensities were 
compared to Tubulin band intensities as the loading control while p42 MAPK and p44 MAPK 
band intensities were used as loading controls for comparing the band intensities of the p42 
and p44 phosphorylated forms of MAPK.  
Results and Discussion 
Matrix properties 
 The collagen matrix scaffold, generated using an electrochemically induced collagen 
aggregation procedure, displays physical properties such as optical transparency, mechanical 
stiffness, and water incorporation that are desirable for use in artificial ocular implants.[1] The 
matrix formation process is based on isoelectric focusing between parallel plate electrodes,[9] 
resulting in a sheet-like scaffold (Figure 1a) with a thickness ~ 500 µm when dried (as 
measured by AFM). When fully hydrated, the scaffold swells to a thickness of several 
millimeters and becomes softer and more viscous. This is the condition under which the cell 
culture studies were conducted since this is analogous to in vivo conditions. The lateral 
dimensions of the scaffold are determined by the size of the electrodes; those used for this 
study are ~ 1 cm x 2.5 cm. Previous studies have shown that these layers are comprised of a 
fibrillar collagen core with a monomeric collagen overlayer, based on morphological features 
in atomic force microscopy images and from characteristic amine-related peak positions in 
Raman spectroscopic data.[9] Our matrix has high optical transparency in the visible range, 
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with over 90% transmittance above 400 nm (Figure 1b). This is only slightly lower than the 
95-99% transmittance observed in natural corneas.[1] 
 The elastic modulus of the matrix can be controlled with the addition of different 
cations during membrane formation;[9] the membranes used here have Young’s elastic moduli 
of  0.10-0.22 GPa when fully desiccated, as calculated from nanoindentation measurements. 
These are similar to values obtained by others for partially desiccated human corneas, which 
are considerably higher than values obtained on fully hydrated corneas, as expected.[10] We 
note that in vivo, scaffolds would exist in a fully hydrated state. These mechanical properties 
make the scaffolds quite robust during routine laboratory handling, and they can be dried and 
rehydrated multiple times without changing the mechanical stiffness of the membrane.[9]  
 We note that this electrochemical assembly method does not apply equally well to all 
types of proteins. For example, replacing collagen with either fibronectin or bovine serum 
albumin does not lead to mechanically stable membranes. Instead, the resulting products with 
these two other proteins were small, mm-sized globular aggregates that remained suspended 
in the electrolyte rather than aggregating together. 
 
Cell viability 
A biocompatibility test ensured that cells cultured in the presence of the matrix are 
viable. MK/T-1 cells that adhere to the electrochemically induced matrix scaffold appear 
robustly healthy, adhesive, motile, and display pseudopodia (Figure 2a). In addition, MK/T-1 
cells that adhere to the matrix scaffold appear to retain the property of contact inhibition, 
since we did not observe the cells piling up on each other when in contact with our 
electrochemically induced matrix. This property is not due to a low cell concentration, but 
rather a property of the cell line itself, as described in earlier studies.[6]  The observed cell 
morphologies are similar to those when these cells are grown on surfaces designed to 
maintain viability, such as a tissue culture plastic control (Figure 2b). Hematoxylin and eosin 
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(H&E) stained paraffin embedded sections (Figure 2c,d) showed no signs of the fragmented 
or shrivelled nuclei that would be characteristic of programmed cell death (apoptosis or 
pyknosis). In stark contrast to the good cell adherence on the electrochemical scaffold and the 
plastic control, the fibrillized collagen control did not induce any specific cell positioning or 
flattening (Figure 2e). This indicates that the collagen treatment procedure prior to cell 
culturing can have a critical impact on the fundamental nature by which the scaffold can 
support viable cells.  
 
Cell activity 
A surprising and unique result of subsequent cell culture studies is that our 
electrochemically induced collagen matrix does not appear to stimulate the MK/T-1 cells into 
a more proliferative state, in which the cells would duplicate their DNA more actively. A 
granular nuclear staining pattern for the cell cycle marker proliferating cell nuclear antigen 
(PCNA) appears in the control plastic-replated cells and control thermally fibrillized collagen 
replated cells (Figure 3a,b). In contrast, the MK/T-1 cells display a diffuse nuclear pattern of 
expression when adhered to the electrochemically induced collagen scaffold (Figure 3c). 
Negative control immuno-staining reactions (shown in Figure 3d for plastic-replated cells) 
confirm the specificity of the anti-PCNA stain. Previous studies have shown that diffuse 
PCNA expression, such as that displayed by our electrochemically induced matrix-cultured 
cells, is observed in cells that are outside the DNA replication (S-phase) portion of the cell 
cycle, while granular nuclear PCNA expression coincides with cells in S-phase that are 
actively replicating their DNA.[11] Although our investigations show that the spatial pattern of 
intracellular localization of PCNA in electrochemically induced matrix and plastic replated 
cells differ, the level of expression of PCNA by western blot analyses revealed no significant 
quantitative difference between the two conditions (Figure 4a).  
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We assessed the DNA replication question more directly by replating the MK/T-1 
cells in the presence of 5-bromo-2-deoxyuridine (BrdU, a synthetic analogue of thymidine) on 
both the electrochemically induced collagen scaffold and the control plastic replating 
conditons. High levels of BrdU inside the cells indicate active DNA replication, and its 
incorporation was measured by immunostaining. While plastic-replated control cells 
incubated with BrdU displayed robust BrdU staining (Figure 5a), the level of BrdU staining 
in nuclei of electrochemical matrix replated cultures (Figure 5b) was similar to background 
levels observed in negative control immunostaining (Figure 5c). It is important to note that, 
while the same numbers of cells were simultaneously replated onto either the plastic or the 
electrochemical matrix, the cells were ansynchronous populations, implying that our 
experiments sampled cells at different points in their life cycles. Since no observable fraction 
of the cells were actively replicating DNA as evidenced by the lack of BrdU stained cells, we 
conclude that cells on our electrochemically induced matrix appeared more quiescent than 
proliferative. This response is very different from the active DNA replication observed, based 




 Quiescent cells are known to maintain an active metabolism,[12] and we observed this 
in the electrochemically induced matrix cultures. Figure 6a,b shows prominent expression of 
a marker related to cell motility, alpha-smooth muscle actin (ASMA), and subsequent western 
blot analyses (Figure 4b) show that ASMA expression is slightly but significantly upregulated 
in matrix replated cultures compared to plastic replated cultures (average fold increase with 
standard error of mean 1.7 +/- 0.02 ).  
In addition, in electrochemically induced matrix replated MK/T-1 cells, we observe 
specific patterns of expression of activated intracellular signalling molecules that are involved 
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in a number of processes such as cell growth and differentiation. The levels of an activated 
signalling cascade for an extracellular signal-regulated kinase (phospho-p42 mitogen-
activated protein kinase, MAPK) was significantly upregulated in electrochemically induced 
matrix-replated cells compared to plastic-replated cells (average fold increase with standard 
error of mean 8.3 +/- 0.47), as seen in Figure 4a and 6c. On the other hand, levels of activated 
phospho-p44 MAPK (Erk1) were not significantly different in matrix-replated versus plastic 
replated MK/T-1 cells, as shown in Figure 4a.  
These metabolic findings are significant because they suggest our electrochemically 
induced collagen matrix triggers differentiative rather than prolifative signaling in the MK/T-
1 cells. Earlier work demonstrates that MK/T-1 cells upregulate a similar signaling pathway 
(p38 MAPK) and ASMA expression when exposed to a transforming growth factor (TGF-b 
2).[6] Others have clearly shown that cells adhering to collagen can activate the p44/42 MAPK 
signaling pathway based on induction of phospho-p44/42 MAPK expression.[13] Transient 
activation of the p44/42 MAPK signaling pathway has been previously associated with cell 
proliferation, while sustained activation, as we observe here in electrochemically induced 
matrix scaffold replated MK/T-1 cells, has been linked to differentiation.[14] This earlier work 
also showed that the regulation of the kinetics of p44/42 MAPK activation is one of the 
mechanisms involved in the differentiation of neuronal cells. While this limited literature 
indicates the importance of sustained p44/42 MAPK activation in cell differentiative 
responses, we are not aware of any other studies showing specific activation of only p42 
MAPK in a cell differentiative response to collagen as we observed here in the collagen 
matrix replated MK/T-1 cells. This exciting finding merits further study since it suggests that 
the electrochemically produced matrix scaffold might impart unique MAPK signalling 
properties to the cells it contacts. 
Matrix modifications 
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Although it is not yet clear which specific attributes of our electrochemically produced 
collagen matrix enable it to stall the proliferation of the immortalized MK/T-1 cells, control 
experiments using collagen that was thermally fibrilized (with no electric field) suggest that 
the presence of the collagen itself does not quell cell proliferation. This is evident in the 
comparisons of PCNA pattern of expression described in Figure 3. The cells themselves also 
play a key role in the non-proliferation. In the electrochemically assembled matrix, there are 
clearly identifiable areas onto which MK/T-1 cells do not spread (Figure 2c, 3b, 6b,c,d). This 
suggests that cell-cell contact inhibition of the MK/T-1 cells cannot be the sole contributing 
factor to the apparent quiescence we observe. We note that others have used similar 
isoelectric focusing methods, but with a different electrode geometry, to produce aligned one-
dimensional collagen bundles rather than our two-dimensional collagenous sheets.[15] Their 
cell growth studies, involving fibroblasts suited for tendon or ligament repair, demonstrate 
cell viability but do not address the possibility of quiescence. Thus, while the degree of 
collagen aggregation appears to be one factor affecting cell quiescence, there is more to learn 
about controlling these complex matrix-cell interactions.  
Conclusion 
Our cell-culture studies show that electrochemically prepared collagen matrices offer three 
important attributes for a synthetic cornea cell scaffold. First, the matrices display high optical 
transparency in the visible range, with over 90% transmittance above 400 nm. Second, the 
matrix encourages cell attachment near its surface, which keeps the cells near the interface 
and may improve their reactivity. Third, the collagen matrices appear to stimulate signaling 
pathways in the cornea-specific MK/T-1 cells and support contact inhibition without overly 
stimulating cell proliferation. This scenario might also be advantageous in contexts beyond 
cornea applications where viable and metabolically active, yet quiescent, cellular coatings are 
required on artificial biomaterial surfaces. Thus, this scaffold does more than merely support 
viable cells; our evidence shows that there are significant differences in the way cells 
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proliferate on our electrochemically assembled collagen scaffolds compared to collagenous   
scaffold material assembled by other methods. For these reasons, the MK/T-1 cell- 
electrochemically induced collagen matrix scaffold co-culture system is a novel and 
potentially useful model in which to study the interactions of mammalian cells on a new 
artificial biomaterial, which could be an important step toward better engineering of artificial 
tissues.  
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Figure 1. (a) A scanning electron micrograph highlights the sheet-like character of the 
electrochemically prepared collagen scaffolds. (b) A representative transmittance spectrum 
from a hydrated electrochemically prepared collagen matrix (prior to incubation with cells) 
demonstrates its high optical transparency throughout the visible region (400-700 nm). 
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Figure 2. Phase-contrast optical microscopy (a,b) and H&E stained paraffin sections of 
pelleted co-cultures (c,d,e) show cell morphologies that indicate robust and healthy adherence 
and motility. For these images, cells were replated simultaneously onto the electrochemical 
collagen matrix scaffold (a,c), tissue culture plastic (b,d) or a control sample of thermally 
fibrillized collagen (e).  The scale bar in (a) indicates 50 µm for panels (a,b) while the scale 
bar in (c) indicates 50 µm for panels (c,d,e). In (e), “m” denotes the fibrillar collagen control 
matrix. 
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Figure 3. Cell proliferation marker expression differences, when staining for PCNA, are 
indicated by the contrast among (a) punctate nucleoplasmal staining in plastic-replated cells, 
(b) punctate nucleoplasmal staining on control thermally fibrilized collagen, and (c) the 
diffuse staining for cells replated on the electrochemically produced matrix. In (c), “m” 
denotes the matrix. Negative control immunostaining reactions (shown in (d) for plastic-
replated cells) confirm the specificity of the anti-PCNA stain. The scale bar indicates 50 µm 
in (a-d).  
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Figure 4. Western blot analysis of (a) PCNA protein expression, phospho-MAPK (phospho-
p42 and phospho-p44), total MAPK (p42 and p44), and (b) ASMA, tubulin of either plastic-
replated or electrochemical matrix-replated MK/T-1 cells. Densitometry analysis of western 
blot data reveal a slight but significant upregulation of ASMA expression in the 
electrochemical matrix replated cultures and a significant upregulation of p42-phosho-MAPK 
expression in electrochemical matrix replated cultures. 
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Figure 5. The contrast between strong staining for BrdU in (a) plastic-replated cells and (b) 
the relative lack of BrdU staining for electrochemical matrix-replated cells (where “m” 
denotes the matrix) indicates a decrease in proliferative response of the MK/T-1 cells on the 
matrix. Negative control immunostaining reactions (shown in (c) for plastic-replated cells) 
confirm the specificity of the BrdU stain. The scale bar shows 50 µm for (a-c). 
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Figure 6. Cell signaling is confirmed by retention of stain for ASMA in cells (a) replated onto 
tissue culture plastic and (b) replated onto the electrochemical collagen matrix. Evidence of 
robust phospho-MAPK (phospho-p42 and phospho-p44) staining (c) and cell morphologies in 
H&E counterstains in adjacent sections of the matrix (not shown) provide further positive 
controls for cell signaling activity and cellular integrity. (d) Negative control immunostaining 
reactions confirm the specificity of the ASMA stain. The scale bar indicates 50 µm in all 
panels, and “m” denotes the matrix. 
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A transparent, electrochemically produced collagen matrix shows promise as a scaffold 
for cornea repair. Immortalized corneal fibroblasts seeded onto this matrix are viable but do 
not proliferate, similar to their behavior in a native corneal environment. This unusual matrix 
property – the ability to contain cell growth – could also be relevant for controlling cell 
growth in engineered tissues. 
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